These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 22428773)
21. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial. Shaheen NJ; Denison H; Björck K; Karlsson M; Silberg DG Gut; 2013 Sep; 62(9):1248-55. PubMed ID: 22730470 [TBL] [Abstract][Full Text] [Related]
22. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971 [TBL] [Abstract][Full Text] [Related]
23. The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers. Rohof WO; Lei A; Hirsch DP; Ny L; Astrand M; Hansen MB; Boeckxstaens GE Aliment Pharmacol Ther; 2012 May; 35(10):1231-42. PubMed ID: 22469098 [TBL] [Abstract][Full Text] [Related]
24. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors. Yadlapati R; Tye M; Roman S; Kahrilas PJ; Ritter K; Pandolfino JE Clin Gastroenterol Hepatol; 2018 Feb; 16(2):211-218.e1. PubMed ID: 28911949 [TBL] [Abstract][Full Text] [Related]
25. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790 [TBL] [Abstract][Full Text] [Related]
26. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614 [TBL] [Abstract][Full Text] [Related]
27. The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease. Pauwels A; Altan E; Tack J Neurogastroenterol Motil; 2014 Apr; 26(4):581-8. PubMed ID: 24533836 [TBL] [Abstract][Full Text] [Related]
28. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Kadakia SC; Kikendall JW; Maydonovitch C; Johnson LF Am J Gastroenterol; 1995 Oct; 90(10):1785-90. PubMed ID: 7572895 [TBL] [Abstract][Full Text] [Related]
29. Baclofen for the treatment of pediatric GERD. Vadlamudi NB; Hitch MC; Dimmitt RA; Thame KA J Pediatr Gastroenterol Nutr; 2013 Dec; 57(6):808-12. PubMed ID: 23838820 [TBL] [Abstract][Full Text] [Related]